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The objectives of this thesis were to design a method
for evaluation of the diagnostic potential of available
indicators of coronary heart disease (CHD) and to present a
systematic, quantitative procedure for aiding in its diag-
nosis. A sample space of patients was divided into two
mutually exclusive groups, those with angiographic evidence
of CHD, and those with no CHD. Active duty or retired
military men between the ages of 30 and 67 years constituted
the sample space. Tests and risk factors were available in
the medical literature that a doctor could view as an indi-
cator or contraindicator of CHD. A vector of these possible
indicators was established and the diseased group was com-
pared to the non-diseased group in an effort to evaluate
the diagnostic potential of the indicators. This was don
by discriminant analysis in conjunction with a Bayesian
method of weighting the importance of test results. The
important indicators were then used to formulate a model for
diagnosing CHD based on a Bayes ? decision technique.
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I. INTRODUCTION
Heart attacks resulting from coronary heart disease
(CHD) cause more deaths each year than cancer, strokes, and
accidents combined. These deaths also include a broader
spectrum of the population than in previous years. In the
last century, heart disease was viewed as a natural result
of growing old. But with the transition from a rural to
an urban society, and the inherent traits of tension, rich
diet, and lack of exercise, the propensity for heart disease
has increased. This increase can be seen in the steady
rise in the number of heart attacks among men over the past
20 years. The American Heart Association reported that of
the 675,000 deaths from CHD expected during the past year,
176,000 would have been men and women under the age of 65
[Ref. 16].
Medical capabilities have greatly increased, giving
coronary heart disease patients a greater probability of
survival once they are under medical care, but since over
half of those who die never reach a hospital, the problem
of predicting coronary heart disease becomes very important.
This diagnostic problem gains additional importance because
of the lack of a proven method for the treatment of CHD in
its advanced stages. Furthermore, there is an increased
presence of asymptomatic CHD that may go undetected with
present diagnostic criteria.

In this study an attempt has been made to consolidate
a spectrum of risk factors that can be incorporated into
diagnostic procedures for CHD. Specifically, the objectives
were to design a method for evaluation of the diagnostic
potential of available indicators of CHD and to present a
systematic, quantitative procedure for aiding in its diagnosis
A sample space of patients was divided into two mutually
exclusive groups, those with angiographic evidence of CHD,
and those with no CHD. Active duty or retired military men
between the ages of 30 and 67 years constituted the sample
space. There were certain tests and risk factors available
in the medical literature that a doctor could view as an
indicator or contraindicator of the disease. Having
established a vector of these possible indicators, the
diseased group was compared to the nondiseased group in an
effort to evaluate the diagnostic potential of the indicators.
This was done by discriminant analysis in conjunction with
a Bayesian method of weighting the importance of test
results. The important indicators were then used to





Probabilistic and computer aided designs to aid decision
makers in medical diagnosis have been a promising area of
research for some time, and an abundant literature on these
subjects exists [Refs. 8, 10]. They have had little impact
on the practice of medicine, however, with several charac-
teristic reasons being given. Among them may be mentioned
insufficient data bases because of the poor quality, lack
of uniformity, or inaccessability of medical records. In
addition, there appears to be a lack of understanding and
interface between the medical profession and those who
would apply probabilistic procedures to aid the medical
decision makers.
Recent years have shown an increase in research efforts
aimed at the prevention and diagnosis of CHD. At the
present time, however, coronary arteriography appears to
be the only completely definitive test for the disease
[Refs. 4, 12]. Unfortunately, this is a costly surgical
procedure that requires hospitalization and involves
definite mortality and morbidity factors, depending on the
age and health of the patient. Arteriography is currently
only available at large medical centers because of the
equipment and expertise required.
Some diagnostic models for CHD tend to consider only
symptomatic patients, usually those with typical angina.

This omits many subjects who are asymptomatic, a portion of
which may be suffering from silent heart disease.
The medical literature cites commonly accepted indica-
tors for CHD. Widely used indicators cited are history of
ischemic episodes, age, total cholesterol, triglycerides,
resting EKG , smoking, and family history [Refs. 4, 12, 16].
Less commonly used indicators that are also cited are race,
blood type, and blood pressure [Refs. 4, 9]. In addition,
the exercise test has recently gained widespread acceptance
as a good CHD indicator [Refs. 1, 6]. The relative impor-
tance of this test in conjunction with other indicators
has not yet been thoroughly investigated.
It seems appropriate that a diagnostic model for
predicting CHD should investigate the potential of an
exhaustive list of indicators and tests for the disease.
This diagnostic model should also reduce the subjectivity
in the decision making of the doctor by increasing the




The flow of patients to a cardiac clinic is similar
to the input of any other specialty clinic. A patient may
be referred to the cardiologist by another doctor based
on the results of a physical examination or, if a person
believes that he is suffering from a cardiac or cardiac-
related illness, he may voluntarily seek the advice of the
specialist directly. In either case, by the time a patient
is admitted to the cardiologist's office, there is already
certain data on him that is available to the physician
without specified testing. From that point on, however,
the diagnosis of a possible heart disease is a function of
the doctor's ability to assign relative importance to the
appropriate indicators. Costs of associated testing, the
procedures available, the patient, and the patient's health
may also have a bearing on the doctor's ability to diagnose
correctly.
The cardiologist then may be viewed as a decision maker
who, for each patient, receives an amount of initial infor-
mation I from which he initiates a sequence of decisions,
gaining additional information I ' as a result of testing.






DECISION PROCESSES OF CARDIOLOGIST
Diagnosis
Outcomes
As an illustration of the concepts implied in Figure 1,
consider that a patient is referred to the cardiologist
because he has symptoms of CHD. At decision node D the
doctor evaluates the information he has available. Usually
this is information readily available in the patient's
medical record. Based on this information, the doctor has
two choices at D , diagnosis of the patient or requesting
additional testing.. If, for example, the doctor chooses t >
perform a test, decision node D, represents the choice the
doctor must make from the clinical tests available. Having
made the choice, I ' represents the information that results
from the outcome of the test. The doctor is again faced
with the decision to be made at D , but he now has the new
o




A summary is presented in Table 1 that shows the possible
path of a patient through a diagnostic sequence.

TABLE 1
PATIENT ADMITTED TO THE CARDIOLOGIST
Race, Sex, Age, Height,
Weight, Blood Pressure,
Blood Type, Family History AVAILABLE
of Heart Disease, Smoking INFORMATION (A)
History, History of Ischemic (I )
Episodes
FURTHER TESTING SPECIFIED BY CARDIOLOGIST
Resting EKG
Exercise EKG CLINICAL
Triglycerides TESTS (fi)Cholesterol (I M
Angiogram *• o J
This summary does not dictate a specified sequence of tests
or weightings of relative importance. The information in
(A) is data available (facts about the patient) that are
easily obtained without testing. Tests in (B) require
expert judgment or- clinical procedures and, again, are not
ordered in any sequence of importance. In practice, not
all of the listed indicators are used for decision making.
Some may be considered by a particular doctor to be unim-
portant. It is also difficult to assign subjective proba-
bilities to some of the indicators about which little is
known. Furthermore, it is impractical to correlate the




In general, there are two approaches to medical decision
problems. The first is to develop and perfect a model that
predicts as well as or better than a physician. The second
approach consists of improving ways to aggregate, weight,
and use information available to the physician so that his
personal diagnosis will be conducted from a substantially
sounder base. This latter approach, which is commonly
called "bootstrapping" [Ref. 10] was the one selected for
this study.
A set of CHD indicators was identified and evaluated
experimentally using discriminant analysis. A proposed
method of assigning weighting factors based on the "posterior
odds" of the various indicator levels was incorporated into
the analysis. These results were then integrated into a
Bayesian diagnostic model.
A. INDICATORS AND WEIGHTING FACTORS
At decision node D, of Figure 1, the doctor must decide
what test to use next in his evaluation of the patient. To
do this he must have a knowledge of what indicators of CHD
have been evaluated and the amount of additional information,
I ', he can expect to obtain from these indicators. Compli-
cating the doctor's evaluation is the division of the
indicators into two types, qualitative and quantitative.
The quantitative indicators are tests in which the outcome
11

is represented on an acceptable numerical scale. Of the
indicators used in this paper, only triglycerides, choles-
terol, age, and blood pressure were quantitative variables.
The other indicators shown in Table 1 (except height and
weight which were not used) have results which have no
numerical scale and must be interpreted qualitatively.
For example, the indicator called history of ischemic
episodes requires the patient to verbalize his history of
chest pain. Also included in the category of qualitative
indicators are tests in which the result is numerical but
lacks meaning unless expressed in qualitative terms. The
exercise EKG result, for example, is in millimeters of
depression (or elevation) of the S-T segment, but is inter-
preted in terms of being positive or negative.
As pointed out previously, these indicators and their
relative merit were determined from clinical judgment and
varied among cardiologists. In addition, the relative impor
tance of various outcomes of any specific test also varied
among doctors. To alleviate these problems, a two-step
procedure was used. First, the outcomes of the qualitative
tests were assigned weighting factors using Bayes ' Theorem.
Second, the qualitative variables and quantitative variables
were integrated into a relative ranking using a stepwise
discriminant analysis computer routine [Ref. 11].
Consider a particular qualitative variable i for which
P(t
i
-|D) is the conditional probability of outcome j
12

given a patient has CHD. The posterior probability of CHD







^ P(t |D)P(D) + P(t |D)P(D)
where P(D) is the presumably known prior probability of CHD
Each of these probabilities on the right hand side of
equation (1) can be estimated from past data. The results
are a vector of values for the outcomes of a specific test
which could then be used with the outcomes of other tests
in a stepwise discriminant analysis computer routine. How-
ever, in order to give more meaning to the weighting fac-
tors, w.
.




lin {P(D t. v )}^ m:
where it was arbitrarily decided to use the minimum outcome
in order to show increasing likelihood of disease as the
value of the weighting factor increased.
Consider the following simple example to illustrate the
procedure for computing weighting factors. Suppose it is
desirable to find weighting factors for the qualitative
variable "race" (i = R) which for the purpose of illustration,
has two outcomes: NEGRO (j = 1) and CAUCASIAN (j = 2).
Suppose further that the prior distribution of CHD is
13

P(D) = 0.1 and data reveals that P(tR1 |D) =0.2 and
P(t R1 |D) = 0.4. It then follows from equations (1) and (2)
that the weighting factors are wR , = 1.0 and wR2 = 2.46.
This method of computing the weighting factors {w..:i=l,
. .
.
,n; j=l, . .
.
,m} provides a consistent means of assigning
scores to each of the qualitative variables. This was done
for a particular set of indicators examined in this study
and the results are given in Section VI. Stepwise linear
discriminant analysis [Ref. 11] could, at this point, be
used to develop a linear prediction function L = v \ X
i=l * i
where X is the set of all test variables (quantitative and
qualitative) , A is the set of all coefficients assigned by
the computer routine, and m is the number of tests. Maha-
lanobis distance could then be used as the discrimination
criterion.
Cohn [Ref. 4] used this type of linear discriminant
analysis in its predictive role in a medical decision con-
text. Use of discriminant analysis for prediction was
discarded in this paper for two reasons. The technique is
a valid one when the underlying distributions of the random
variables of the two samples (in this case, the test results)
are distributed normally with equal covariance matrices (a
linearity assumption) . A preliminary investigation indicated
that the variance of the test results in the two samples did
not appear to be equal. Additionally, the normality
14

assumption did not appear to be valid in this application.
The test results had a combination of binomial, multi-
nomial, and approximately normal distributions. Considera-
tion of all distributions as normal did not have a sound
theoretical basis.
The actual purpose of conducting this portion of the
analysis was to identify the relative importance among the
variables. This was accomplished by ordering the resulting
F-statistics associated with the coefficients (X's) of the
variables (X's). The F-statistic is the ratio of the vari-
ability of the means of the individual test results in
each sample to the pooled variance of the test results. F
will be large when there is a large difference between the
mean results of a test in the CHD and the no CHD groups.
Likewise, the smaller the F, the closer together are the
mean results for a particular test in the CHD and no CHD
groups. Thus, an ordering of these computed F-statistics
from largest to smallest may be considered an ordinal
ranking of the diagnostic power of the various indicators.
B. BAYESIAN DIAGNOSTIC MODEL
The foregoing procedure, of Section IV. A. , for determining
the relative diagnostic power of the available tests of
indicators provides criteria for the cardiologist to select
appropriate tests at decision node D, in Figure 1. A
Bayesian method for quantifying the information I and
additional information I ' is now presented.-
15

The development of this model was based on two major
assumptions. First, it was assumed that patients being
tested either had CHD or did not have CHD. Thus, the case
of a patient having multiple diseases was excluded here.
The second assumption was that the data, on both qualita-
tive and quantitative variables were conditionally inde-
pendent .
Let
P(D.) = apriori probability of CHD (D,)
,
or no CHD (D?^)
P(D. IS. , . .
.
,S ) a posterior probability of D. givenl'ln r r J 1 b
symptoms, or indicator levels, S.,...,S .






1 * n 1
The first assumption merely requires that P(D.) = P(D-i)
or P(D
2
) = P(D,). The second assumption, in terms of the
above notation, says that
n
P(S, ,. . . ,S p.) = n PfS. p.) (3)





• P(D.) n P(S. p.)






which is in terms that can be calculated using subjective
probabilities (doctor's medical opinions) and frequentistic
procedures [Ref . 8]
.
The majority of the conditional probabilities were
calculated using frequentistic procedures. Subjective
probabilities were used when the data base was insufficient.
a. y^
In cases where a patient was missing the j symptom on his
medical records or the patient was unable to take the test,
the conditional probabilities P(S.|D,) and P(S. |D ? ) were
J J. J Z
set equal to .5 (i.e., P(S.|D
1
) and P(S.|D ) were equally
likely and thus had no influence on the associated proba-
bilities) .
The Bayesian diagnostic model was developed because it
provided several distinct advantages over general discrimi-
nant analysis techniques commonly used for medical decision
making. The first advantage was the use of subjective
apriori probabilities. Each doctor has his own feelings
and experience concerning the probability of CHD in a patient
The second advantage was that the Bayesian model is self-
updating. After each patient has been diagnosed, his charac-
teristics can be easily added to the data providing new
apriori probabilities. This allows the doctor to see trends
that may develop, providing the stimulus for research in
these areas. The data base is continuously enlarged in this
manner, improving the diagnostic accuracy of the model. The
third advantage is that CHD is only a small part of the
17

diagnostic problem facing the doctor. The Bayesian approach
allows for the expansion of the hypothesis. In the present
model only one hypothesis is treated, no CHD or CHD . How-
ever, this could easily be expanded to no disease, CHD,
liver disease, etc. An important aspect of this is that as
the number of data points in the data vector and the number





V. CLINICAL TESTS AND OBSERVATIONS
Data was derived from three sources. The first source
was generated by testing a sample of individuals undergoing
routine physical examinations at Fort Ord Army Hospital.
A collection sheet was developed to record the data that
was simple yet comprehensive enough to see if trends
developed in areas not considered important in the initial
analysis (See Appendix A)
.
The second source of data was the medical records at
Letterman General Hospital, San Francisco. A data sheet
similar to that of the Fort Ord sample was used. However,
several problem areas were encountered. The first was the
problem of definition and interpretation. Many records
showed information such as "positive" family history with
no explanation of what the doctor's opinion was based on.
Others had entries such as "30 pack year history" of
smoking. This type of data does not differentiate between
two packs per day for 15 years or three packs per day for
10 years. Since intensity of smoking may be an important
variable, much valuable data were lost. Another problem in
this area was the omission of data that were assumed to be
normal. If a patient's test result was abnormal, the
result was noted in the patient's record. (However, if
nothing was noted, it was not clear whether the test result
was normal or that the result was omitted.) It is clear
19

that personalities become an important factor in the writing
and in the reading of medical records. However, it is felt
that as more records are automated these problems will be
greatly reduced.
The problem of missing data was the major obstacle
encountered from the CHD population. The majority of the
patients did not have all the test results in their files.
The only solution to this problem is to increase the sample
size so that patients with missing data can be removed from
the sample. But since one of the major objectives of this
paper was to develop a method, the missing data problem will
not be considered within this framework. For information
concerning decision making with missing data, see Ref. 4.
The third source of data was the medical literature.
This was used to establish apriori probabilities of CHD
when it was felt that the experimental sample was too small,
making the sample probabilities very sensitive to error
[Ref. 7].
The partitioning of the sample space into two parts,
CHD and no CHD, implied that the subject in the healthy
group was not suffering from any disease, and that a sub-
ject in the CHD group was suffering from CHD only. Other
diseases may have adversely affected the test results of
either group. In the formation of the sample, care was
taken to eliminate all subjects that had other diseases.
In the determination of positive or negative family
history, the age of 65 was considered the cut-off. If a
20

blood relative had CUD prior to age 65, the result was
positive. Although this cut-off was arbitrary, it was the
one most consistent with the available literature. It
can be easily changed, however, if another cut-off is
desired.
When checking for chest pain, the existence of any
chest pain that was not categorized as angina was listed
as undetermined origin since none of the subjects were
known to have diseases which might explain the pain.
The reading of the resting EKG was done by a cardiologist
whose experience and subjective opinions must be considered




Sensitivity analysis was conducted in the following
areas
:
1. The effect of weighting factors on the ordinal
ranking of the qualitative indicators was investigated.
Table 2 shows how changes in weighting factors proved to
markedly influence the diagnostic ordering of the indica-













Smoking History (per day)
Non-smokers 1 1
Less than 1/2 pack 4.6 2
About 1 pack 4.5 3
Greater than 1 pack 6.3 4
History of Ischemic Episodes
None 1 1
Chest pain 8 2







ST-T abnormalities 20 3







ST depression < 1mm 25 . 2
ST depression >^ 1mm 150 3
All other indicators were quantitative. The following
















Systolic Blood Pressure .9659
Family History .1607
Triglycerides .0485
Diastolic Blood Pressure and Race were omitted because of
an insignificant F value for this particular sample.
Sample Clinical Weighting Procedure
Exercise EKG 13.0179

















2. Diagnostic accuracy was investigated by varying the
prior probability of disease, P(D), and assuming P(D|S,,...
S ) > 0.5 indicated CHD. These values for Table 4 were
n'
determined from patients having eight or more test results.
TABLE 4







** False Negative = patient has CHD but is diagnosed as
not having CHD.
*** False Positive = patient does not have CHD but is
diagnosed as having CHD.
3. After the model had been developed and the condi-
tional probabilities had been determined, data on CHD
patients were obtained from Walter Reed Hospital. Using the
originally determined probabilities, these patients were
tested with the Bayes' diagnostic model and 12 out of 14
were correctly diagnosed as having CHD. Again, a P(D|S-,...,
S ) > 0.5 indicated CHD.
n
The Walter Reed patients were then added to the original
sample to update the prior probability of disease. The
25

changes in the prior probabilities were so small that they
had no effect on the diagnostic results.
4. Diagnostic accuracy was investigated by varying
















VII. RESULTS AND CONCLUSIONS
As previously stated in Section I, the objectives of
the study were to design a method for the evaluation of the
diagnostic potential of available indicators of CHD and to
present a systematic, quantitative procedure for aiding in
its diagnosis. The indicators of CHD were investigated by
comparing specific test results from a CHD sample and a
healthy sample with no CHD.
The stepwise discriminant analysis, as presented in
Section IV. A. , using all variables was performed on a CHD
sample size of 106 compared to a no CHD sample size of 56.
The weighting factors were determined by the Bayesian
approach (tabulated in Table 3, Section VI). An important
result of the discriminant analysis program was the ordering
of variables and their associated F-statistics which may
be viewed as an ordering of the relative diagnostic impor-
tance of the tests- (see Table 4, Section VI). This method
of assigning weighting factors to test results in conjunc-
tion with discriminant analysis is a valid procedure for
ordering the vector of tests in their diagnostic importance.
It provides a means for a doctor at decision node D, (of
Figure 1) to determine which test provides the most additional
information I ' from those available to him. Additionally,
the method is particularly valuable and easily adapted to
considering new indicators of disease where no definitive
27

clinical judgment exists or doctors do not agree on the
relative importance of test results.
The Bayes ' diagnostic model (Section IV. B.) was
developed to provide a systematic, quantitative procedure
for aiding in the diagnosis of CHD. It was evaluated by
checking how well it diagnosed patients from a known CHD
group and a known healthy group. The difficulty in obtain-
ing patients with all the required test results was noted
in Section V and resulted in extremely small samples with
complete data to investigate. However, six out of seven
of the CHD group were diagnosed correctly, and 33 out of 33
of the no CHD group were diagnosed correctly. When only
eight or more of the test results were available, the model
diagnosed with 91% accuracy (41 out of 50 in the CHD group
were diagnosed correctly and 52 out of 52 of the no CHD
group were diagnosed correctly) . These results were based
on using a posterior probability of disease of .50 as the
cut-off probability (i.e., P(D|S
1
,...,S ) >_ .50 indicated
CHD) . The variation of the cut-off probability (see
Section VI) demonstrated that the diagnostic accuracy
of the model was greatly influenced by the choice of the
cut-off criterion. For example, using a cut-off of .20
instead of .50 reduced the number of false negatives from
nine to four while the number of false positives remained
the same.
As a validation of the Bayes' diagnostic model, 14
known CHD patients from Walter Reed Hospital were diagnosed
28

by the model. Twelve of the 14 were diagnosed correctly.
The validation is not conclusive because of the extremely
small sample tested, but it does indicate that the method
is promising.
It may be desirable to use the methods presented in
a screening program to identify people with high risk of
CHD from a large population. Sufficient doctors may not
be available to examine all of the people to be tested. As
an example of the model's applicability to such a screening
program (where a doctor is not required) diagnostic accuracy
was investigated using the results of the information avail-
able only [referred to in Figure 1 as I and in Table 1
as (A)]. The model diagnosed with 921 accuracy (19 out of
24 in the CHD group were diagnosed correctly and 44 out of
44 in the no CHD group were diagnosed correctly)
.
The Bayesian diagnostic model had a high degree of
accuracy in correct diagnoses. It is easily implemented
and appears to be well adapted to screening studies where
a large population is involved. The model continuously
updates the available patient information from which the
conditional probabilities are calculated and may be useful





VIII. AREAS FOR FUTURE STUDY
As pointed out previously (see Section IV. A) , one of
the main advantages of the approach followed in the paper is
the easy expansion of the number of variables and the number
of patients to be tested. This implies that as the number
of variables is increased, the diagnosis of CHD will improve
The expanded list of variables could also be used to pre-
dict other diseases. Instead of a space of CHD and no
CHD, there is a space of CHD plus other diseases limited
only by logical considerations such as the time, money,
availability of computational equipment, etc. The integra-
tion of this expanded prediction model into routine physical
examinations and patient history could allow preliminary
diagnosis prior to consultations with doctors, helping to
reduce costs and the increasing patient load of doctors.
As presently modeled, diagnosis is based on results of
samples from diseased and non-diseased groups. However,
as more samples are obtained and a history of the patient's
variables (i.e., changes in blood pressure over several
years) is made, the model could be modified to diagnose on
the basis of change in a patient's variables rather than by
comparison with a norm. This would improve diagnosis among
persons suffering from one disease where the diagnosis is
being complicated by the existence of another disease.
The extension of the model to include the diagnosis of
women would require only a change in the prior probability
30

to include a test for sex. Additionally, a statistical
check of the indicators would be necessary to determine if
a new data base including women would be necessary if
women were to be tested.
Once a person has been found to have CHD, a system to
monitor his progress under dieting and exercise control
could be developed from the present model. This could
allow a technician rather than a doctor to periodically
check the patient's indicators.
The definitions used for positive tests throughout
this study were based on current information. Both a
statistical and medical investigation in this area to
better define test results could greatly improve future
models developed on the same principles.
A model to predict the cost of implementing and
operating the proposed diagnostic model should be explored
31

APPENDIX A: SAMPLE DATA COLLECTION SHEET
Name
Date





Family History: Any of the following diagnosed heart diseases
(circle)
Father Uncle
Mother Brother Unknown None
Aunt Sister
Any of the following died of heart disease (circle)
Father Uncle
Mother Brother Unknown None
Aunt Sister
Cigarette smoking in excess of one year? Yes No
If yes: less than 1/2 pack per day
one pack per day
more than one pack per day
History of Ischemic episodes:










ST depression greater than 1 mm
































APPENDIX C: BAYES • DIAGNOSTIC MODEL FORTRAN PROGRAM LISTING
BAYE'S DIAGNOSTIC MODEL FOR CORONARY HEART DISEASE
RFAL*8B,C,D,E,F,G,S,T,U,V,BC,CD,DE,EF,FG,GS,ST,TU,UV,
1W,XY,YZ,ZY,YX,ZF,ZW,ZM,ZB,ZH,Z0,ZG,ZN,ZC,ZD,VW,A,ZA





READ IN PROBABILITIES OF SYMPTOMS GIVEN NO CHD
CODE FOR INPUT OF PROBABILITIES OF SYMPTOMS GIVEN
NO CHD (AND CHD)
1ST LETTER
P-PROSABILI TY OF














4TH LETTER IN A FOUR LETTER CODE
D-CHD
N-NO CHD
4TH LETTER IN A FIVE LETTER CODE
A-ABNORMAL WHEN PRECEDED BY RE, TY, CH, BS, OR BD
A-ANGINA WHEN PRECEDED BY HE
A-BLOCD TYPE A WHEN PRECEDED BY 3T
G-GREATER THAN 1MM DEPRESSION WHEN PRECEDED BY EE
G-GREATER THAN 1 WHEN PRECEDED BY CI
H-l/2 PACK
N-NEGATIVE OR NCKE
O-BLOOD TYPE C, A3 OR B WHEN PRECEDED BY BT
0-1 PACK WHEN PRECEDED 3Y CI
0- OTHER WHEN PRECEDED BY HE









PHEPN , PHE AN, PHENN, PRENN, PRE AN,
1 PR EON, PREON,PEENN,PEEON,PEEGN,PTYNN,PTYAN,PCHAN,PCHNN,
1PBSAN,PBSNN,PBDAN,P3DNN,PDA
100 FORMAT! 8F10.6)



























































PRESSURE COLS. 14-16 NUMERICAL VALUE
C PRESSURE COLS. 19-21 NUMERICAL VALUE
PE COL. 24
I STORY COL. 27
IVE
IVE




















TEROL COLS. 45-47 NUMERICAL VALUE
S. 50-51 NUMERICAL VALUE
50 READ(5.103HNDICtR,ZtBStBD,BT»FN,CI , HIE. RE ,EE,TRY,CHL.
1 AGE
103 FOP MAT ( Alt 4X. F 1.0.
2
X,F3.0,2X,F3 •0.2X.F3.0, 2X.F1.0, 2X.
lF1.0t2X,F1.0,2X.F1.0,2X,FltO,2X,F1.0.2X.F1.0,2X,F3.0.
12X.F2.0)














1 = 1 + 1






MAKE FIRST CHECK FOR AGE GROUP, LESS THAN 34, 34 TO
44* OVER 44
AFTER DETERMINATION1 ASSIGN PRICR PROBABILITY OF CHD
IF( AGE.GT.34)G0 TO 120
PD=.01
GO TO 190









CHECK TO DETERMINE RACE, RECALCULATE PROBABILITY OF
CHD
201 IF(R.EO.0.0)GO TO 301
IF(R.E0.1.0)PDR= (PRCD*PD)/( ( PRCD*PD) + ( PRCN* ( 1.0-PD) ) J
IF(R.EQ.2.3)PDR=(PRND*PD)/( ( PRND^PD ) + ( P RNN* ( 1.0-PD) )
)




CHECK TO DETERMINE BLOOD TYPE, RECALCULATE PROBABILITY
CHD
302 IF(BT.E0.3.3)G0 TO 431
IF(BT.F0.1.0)PDBT=( PBTAD*PDR)/( (PBTAD-PDRJ +
1 (PBTAN* { 1.0-PD R ) ) )




IFCBT.F0.3 .0 )PDBT=(PBTOD*PDR)/( (PBTOD+PDR) +
1<PBT0N*( 1. O-PDRJ )
IF(BT.EQ.4.0)P0B7=(PBT0D*PDR)/( (PBTOD*PDR)+




CHECK TO DETERMINE FAMILY HISTORY, RECALCULATE PROB-
ABILITY OF CHD
402 IF(FN.E0.0.0)G0 TO 501
IF(FN.E0.1.0)PDFN={ P FNPD*PDBT ) / ( ( P FNPD*PDB7 )
*
1(PFNPN*( 1. O-PDBT) )
)
IF(FN.E0.2.0)PDFN=( PFNND V'P DBT) / ( ( PFNND*PDBT) +




CHECK TO DETERMINE CIGARETTE HAB I TS ,RECALC ULATE PROB-
ABILITY OF CHD
502 IF(CI.EO.0.0)GO TO 601
IF(CI.FQ.1.0)PDCI = ( PCIHD*PDFN)/ ( ( PC I HD*PDFN ) +
1(PCIHN*( 1. O-PDFN) )
IF(CI.EQ.2.0)PDCI = (PCI0D=-'PDFN) /( ( PC IOD*PDF N ) +
1 (PCI ON* (1. O-PDFN) ) )
IF(CI.F0.3.0)PDCI=( PCIGD*PDFN) /( (PCIGD* PDFN)+
1 (PCIGN- ( 1. O-PDFN ) J
)
IF(CI.E0.4.0)PDCI=( PCIND*PDFN)/ ((PCIND*PDFNJ+






CHECK TO DETERMINE HISTORY OF ISCHEMIC EP I SODESt RECAL-
CULATE PROBABILITY OF CHD
602 IFfHIE.EQ. J.O) GO TO 701
IF(HIE.EO.l.O) PDHE=(PHEPD*PDCI ) /( { PHEPD* PDCI ) +
1 (PHEPN*(1.0-PDCI ) ) )
IF (HIE. EO. 2.0) PDHE=(PHEAD*PDCI )/( ( PHE AD* PDC I J +
1 (PHEAN--M 1.0-PDCI ) ) )
IF(HIE.EC.3.0)PDHE=(PHZND*PDCI )/( ( PHEND*PDC I ) +




CHECK TO DETERMINE RESTING EKG RESULTS, RECALCULATE
PROBABILITY OF CHD
702 IF(RE. EO.0.0 JGO TO 801
IF(RE.EQ.1.0)PDRE=( PREND*PDHE)/ ( ( PR END* PDH E )
+
KPREMN-M 1.0-POHE) ) J
IF1RE.E0.2.0 )PDRE=(PREAD^PDHE}/ ( ( PR EAD*PDHE ) +
l(PREAN--( 1.0-PDHE)) )
IF(RE.EQ.3.0)PDRE=(PREQD*PDHE)/< ( PREQD* PDH E J
1 (PREQN-'-- (1.0-PDHE) ) )






CHECK TO DETERMINE EXERCISE EKG RESULTS, RECALCULATE
PROBABILITY OF CHD
802 IF(EE.EO.0.0)GO TO 901
IF(EE.EQ.1.0)PDEE=(PEEND*PDRE)/((PEEND*PDRE)+
1 (PEENN*-- (1.0-PDRE) ) )
IF(EE.E0.2.0)PDEE=( PEE OOSPORE ) / ( ( PEEOD* PDRE ) +
1 (PEEONM 1.0-PDRE ) ) )
IF(EE.GE.3.0)PCEE=( PEEGD=r-PDRE )/ UPEEGD*PDRE) +




CHECK TO DETERMINE TRIGLYCERIDES RESULTS, PECALCULATE
PROBABILITY OF CHD
902 IF(TRY. EO.0.0) GO TO 925
IF (TRY. EG). 1.0)PDTY=(PTYND*PDEE) /( ( PTYND* PDEE ) +
1 (PTYNN*( 1.0-PDEE) ) )
IF(TRY.GE.2.0)PDTY=(PTYAD*PDEE)/((PTYAD*PDEE)+




CHECK TO DETERMINE CHOLESTEROL RESULTS, RECALCULATE
PROBABILITY OF CHD
926 IF(CHL. EO.0.0) GC TO 95
IMAGE. GT. 29.0 )G0 TO 930
IF(CHL.GT.240JPDCL=(PCHAD*PDTY)/( (PCHAD*PDTY)+
1(PCHAN*( 1. O-PDTY) )
IF(CHL.LE.240)PDCL=(PCHND*PDTY)/( ( PCHND* PDTY)
+
1 ( PCHNN*(1. O-PDTY) )
GO TO 951
930 IF(AGE.GT. 39.0 JGO TO 935
IF(CHL.GT.2 7 0) PDCL= (PCHAD*PDTY )/ ( ( PCHAD*PDTY )
37

1(PCHAN*( 1. C-PDTY) )
)
IFCCHL.LE.270)PDCL=(PCHND*PDTYJ/{ ( PCHND*PDTY)+
1 (PCHNN* (1. D-PDTY) ) )
GO TO 951
935 IF(AGE.GT.49.0 )GO TO 945
IF(CHL.GT.310) PDCL = ( PCH AD* PDTY ) / ( ( PCHAD*PDTY )
+
1 (PCHAN*( l.O-PDTY) ) )
IFCCHL.LE.310) PDCL= ( PCHND* PDTY ) / ( ( PCHND*PDTY )
lCPCHNN-"'( 1. 0-PDTY)) )
GO TO 951
945 IF(CHL.GT.330) PDCL= ( PCHAD*PDTY )/ ( ( PCHAD*PDTY )+
1(PCHAN*( 1. 0-PDTY) )
IF(CHL.LE.330)PDCL=(PCHND*PDTY)/( ( PCHND-J<PDTY ) +




CHECK TO DETERMINE SYSTOLIC BLOOD PRESSURE, RECALCU-
LATE PROBABILITY OF CHD
951 IF(BS.EO.O.O)GO TO 975
IF(BS.GE.140)PDBS=( PBSAD*PDCL)/ ( ( P BS AD-PDCL )
+
1 (PBSAN*( 1.0-PDCL ) )






CHECK TO DETERMINE DIASTOLIC BLOOD PRESSURE, RECALCU-
LATE PROBABILITY OF CHD
976 IF(BD.EQ.O.O)GO TO 990
IF(BD.GT.93)PD8D=(PBDAD*PDBS)/((PBDAD*PDBS)+
1 IPBDAN*( 1.0-PDBS) ) )
IF(BD.LE.9 0)PD3D={P3DND*PDBS)/< ( PBDND^PDBS ) +




FORMAT OF OUTPUT INSTRUCTIONS
991 WRITEC6, 936)1
986 FORMATCO', 3X,'THE FOLLOWING INFORMATION IS MISSING',























1003 IF(MHE.EQ.O)GO TO 1C04
WRITE(6,995)S, T





















































































































































3 . J WR
8X.A8,
0.1 J GO
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SUBJECT # 7 HAS PRCBABILITY 0.979999 OF CORONARY









THE FOLLOWING INFORMATION IS MISSING ON SUBJECT #
NONE
SUBJECT » 8 HAS PRCBABILITY 0.999946 OF CORONARY
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The obiectives of this thesis were to design a method
for
evaluation of the diagnostic potential of available indicators
o£
coronary heart disease (CHD) and to present a systematic
quantitative
procedure for aiding in its' diagnosis . A ^mple space of patients
was divided into two mutually exclusive groups, those
with angio
graphic evidence of CHD, and those with no CHD. Active duty
or
retired military men between the ages of 30 and 67 years
constituted
the sample snace Tests and risk factors were available
m the medical
literature that a doctor could view as an indicator or
pontraindicator
of CHD A vector of these possible indicators was established
and the
diseased group was compared to the non-diseased group in an
f to
evaluate the diagnostic potential of the indicators. This
was done
by discriminant Inalysis in conjunction with a B^esian method of
weighting the importance of test results. The important
indicators were
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